한글목차

호르몬 피임약 동향과 예측

세계의 호르몬 피임약시장은 2024-2030년 CAGR이 3.8%로, 2030년까지 추정 198억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 신흥 경제국에서 호르몬 피임법에 대한 인식이 높아지고 주요 기업이 새로운 피임기구의 연구개발에 대한 투자가 급증하고 있기 때문입니다. 세계 호르몬 피임약 시장의 미래는 복합 호르몬 피임약 시장과 프로게스틴 단독 피임약 시장에서 기회가 있으며 유망한 것으로 보입니다.

부문별 호르몬 피임약

이 조사에는 전 세계 호르몬 피임약의 방법별, 호르몬별, 지역별 예측이 포함되어 있습니다.

호르몬 피임약 시장 인사이트

Lucintel은 피임약에 대한 인식이 높아짐에 따라 피임약이 예측 기간 중 가장 큰 부문으로 남을 것으로 예상하고 있습니다.

이 시장에서는 CHC가 더 큰 부문을 차지할 것으로 보입니다.

아시아태평양은 대상 인구가 많고 주요 기업의 투자가 증가함에 따라 예측 기간 중 가장 높은 성장세를 보일 것으로 예상됩니다.

자주 묻는 질문

Q1. 시장 규모 :

A1. 세계 호르몬 피임약 시장은 2030년까지 약 198억 달러에 달할 것으로 예상됩니다.

Q2. 시장의 성장 예측은 :

A2.세계 호르몬 피임약 시장은 2024-2030년 연평균 3.8%의 성장률을 보일 것으로 예상됩니다.

Q3. 시장의 성장에 영향을 미치는 주요 촉진요인은 :

A3. 이 시장의 주요 촉진요인은 신흥 경제국에서 호르몬 피임법에 대한 인식이 높아지고 새로운 피임기구의 연구개발을 위한 대기업의 투자가 급증하고 있다는 점입니다.

Q4. 시장의 주요 부문은 :

A4. 호르몬 피임약 시장의 미래는 CHC 시장과 프로게스틴만 시장에 기회가 있고 유망합니다.

Q5. 시장의 주요 기업은 :

A5. 주요 호르몬 피임약 기업은 아래와 같습니다. :

• AbbVie
• Afaxys
• Teva Pharmaceuticals Industries
• Bayer
• Organon
• Pfizer
• Agile Therapeutics
• Janssen Pharmaceutical
• Lupin Pharmaceutical
• Pregna International

Q6.향후 최대가 되는 시장 부문은 :

A6. A6.Lucintel은 피임약에 대한 인식이 높아짐에 따라 피임약이 예측 기간 중 가장 큰 부문으로 남을 것으로 예상하고 있습니다.

Q7. 시장에서 향후 5년간 최대가 될 것으로 예상되는 지역은 :

A7.APAC은 대상 인구가 많고 주요 기업의 투자가 증가함에 따라 예측 기간 중 가장 높은 성장을 보일 것으로 예상됩니다.

Q8. 리포트의 커스터마이즈는 가능한가? :

A8. 네. Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 개요

제2장 세계의 호르몬 피임약시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018-2030년 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 호르몬 피임약 시장 동향(2018-2023년)과 예측(2024-2030년)
• 방법별 세계의 호르몬 피임 시장
  • 필
  • IUD
  • 주사
  • 질링
  • 임플란트
• 호르몬별 세계의 호르몬 피임약시장
  • CHC
  • 프로게스틴 온리

제4장 2018-2030년 지역별 시장 동향과 예측 분석

• 지역별 세계의 호르몬 피임약시장
• 북미의 호르몬 피임약시장
• 유럽의 호르몬 피임약시장
• 아시아태평양의 호르몬 피임약시장
• 기타 지역의 호르몬 피임약시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
• 세계의 호르몬 피임약 시장의 새로운 동향
• 전략 분석
  • 신제품의 개발
  • 세계의 호르몬 피임약 시장의 생산능력 확대
  • 세계의 호르몬 피임약 시장의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 주요 기업의 기업 프로파일

• AbbVie
• Afaxys
• Teva Pharmaceuticals Industries
• Bayer
• Organon
• Pfizer
• Agile Therapeutics
• Janssen Pharmaceutical
• Lupin Pharmaceutical
• Pregna International

영문목차

Hormonal Contraceptive Trends and Forecast

The future of the global hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets. The global hormonal contraceptive market is expected to reach an estimated $19.8 billion by 2030 with a CAGR of 3.8% from 2024 to 2030. The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Hormonal Contraceptive by Segment

The study includes a forecast for the global hormonal contraceptive by method, hormone, and region.

Hormonal Contraceptive Market by Method [Shipment Analysis by Value from 2018 to 2030]:

• Pill
• Intrauterine Device
• Injectable
• Vaginal Ring
• Implant
• Patch

Hormonal Contraceptive Market by Hormone [Shipment Analysis by Value from 2018 to 2030]:

• Combination Hormonal Contraceptive
• Progestin Only

Hormonal Contraceptive Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Hormonal Contraceptive Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hormonal contraceptive companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hormonal contraceptive companies profiled in this report include-

• AbbVie
• Afaxys
• Teva Pharmaceuticals Industries
• Bayer
• Organon
• Pfizer
• Agile Therapeutics
• Janssen Pharmaceutical
• Lupin Pharmaceutical
• Pregna International

Hormonal Contraceptive Market Insights

Lucintel forecasts that pill will remain the largest segment over the forecast period due to increasing awareness about the pills.

Within this market, combination hormonal contraceptive will remain larger segment.

APAC is expected to witness the highest growth over the forecast period due to presence of large pool target population and rise in investment by key players in the region.

Features of the Global Hormonal Contraceptive Market

Market Size Estimates: Hormonal contraceptive market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Hormonal contraceptive market size by method, hormone, and region in terms of value ($B).

Regional Analysis: Hormonal contraceptive market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different methods, hormones, and regions for the hormonal contraceptive market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hormonal contraceptive market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the hormonal contraceptive market size?

Answer: The global hormonal contraceptive market is expected to reach an estimated $19.8 billion by 2030.

Q2. What is the growth forecast for hormonal contraceptive market?

Answer: The global hormonal contraceptive market is expected to grow with a CAGR of 3.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the hormonal contraceptive market?

Answer: The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.

Q4. What are the major segments for hormonal contraceptive market?

Answer: The future of the hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets.

Q5. Who are the key hormonal contraceptive market companies?

Answer: Some of the key hormonal contraceptive companies are as follows:

• AbbVie
• Afaxys
• Teva Pharmaceuticals Industries
• Bayer
• Organon
• Pfizer
• Agile Therapeutics
• Janssen Pharmaceutical
• Lupin Pharmaceutical
• Pregna International

Q6. Which hormonal contraceptive market segment will be the largest in future?

Answer: Lucintel forecasts that pill will remain the largest segment over the forecast period due to increasing awareness about the pills.

Q7. In hormonal contraceptive market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness the highest growth over the forecast period due to presence of large pool target population and rise in investment by key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the hormonal contraceptive market by method (pill, intrauterine device, injectable, vaginal ring, implant, and patch), hormone (combination hormonal contraceptive and progestin only), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Hormonal Contraceptive Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Hormonal Contraceptive Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Hormonal Contraceptive Market by Method
  • 3.3.1: Pill
  • 3.3.2: Intrauterine Device
  • 3.3.3: Injectable
  • 3.3.4: Vaginal Ring
  • 3.3.5: Implant
• 3.4: Global Hormonal Contraceptive Market by Hormone
  • 3.4.1: Combination Hormonal Contraceptive
  • 3.4.2: Progestin Only

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Hormonal Contraceptive Market by Region
• 4.2: North American Hormonal Contraceptive Market
  • 4.2.1: North American Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
  • 4.2.2: North American Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
• 4.3: European Hormonal Contraceptive Market
  • 4.3.1: European Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
  • 4.3.2: European Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
• 4.4: APAC Hormonal Contraceptive Market
  • 4.4.1: APAC Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
  • 4.4.2: APAC Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
• 4.5: ROW Hormonal Contraceptive Market
  • 4.5.1: ROW Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
  • 4.5.2: ROW Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Hormonal Contraceptive Market by Method
  • 6.1.2: Growth Opportunities for the Global Hormonal Contraceptive Market by Hormone
  • 6.1.3: Growth Opportunities for the Global Hormonal Contraceptive Market by Region
• 6.2: Emerging Trends in the Global Hormonal Contraceptive Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Hormonal Contraceptive Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hormonal Contraceptive Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: AbbVie
• 7.2: Afaxys
• 7.3: Teva Pharmaceuticals Industries
• 7.4: Bayer
• 7.5: Organon
• 7.6: Pfizer
• 7.7: Agile Therapeutics
• 7.8: Janssen Pharmaceutical
• 7.9: Lupin Pharmaceutical
• 7.10: Pregna International